According to Rigel Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -0,21ย โฌ. In 2022 the company made an earnings per share (EPS) of -0,32ย โฌ a decrease over its 2021 EPS that were of -0,09480ย โฌ.